Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials

Published:2022-07-03 Issue:3 Volume:14 Page:270-282
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Liu Rong¹,Yuan Ying²,Sen Suman³,Yang Xin³,Jiang Qi⁴,Li Xiaoyun (Nicole)⁵,Lu Chengxing (Cindy)⁶,Gönen Mithat⁷,Tian Hong⁵,Zhou Heng⁸,Lin Ruitao²^ORCID,Marchenko Olga⁹

Affiliation:

1. Bristol-Myers Squibb, Berkeley Heights, NJ;

2. The University of Texas MD Anderson Cancer Center, Houston, TX;

3. Novartis Pharmaceuticals Corp., East Hanover, NJ;

4. Seagen;

5. BeiGene, San Mateo, CA;

6. AstraZeneca, Waltham, MA;

7. Memorial Sloan Kettering Cancer Center, New York, NY;

8. Merck & Co., Inc, Kenilworth, NJ;

9. Bayer, Whippany, NJ

Funder

Ying Yuan’s research

National Cancer Institute.

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2022.2081602

Reference51 articles.

1. A simulation‐free approach to assessing the performance of the continual reassessment method

2. A Generalized Continual Reassessment Method for Two-Agent Phase I Trials

3. A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents

4. A Bayesian dose finding design for oncology clinical trials of combinational biological agents

5. Designs for Single- or Multiple-Agent Phase I Trials

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP